CEA Rapid Test: A Reliable Tool for Cancer Monitoring and Early Detection
The burden of cancer continues to grow globally, with colorectal cancer ranking among the most common and deadly malignancies. In this battle, early detection and continuous treatment monitoring are crucial for improving patient outcomes. The CEA test (Carcino-embryonic antigen) Kit developed by Wizbiotech provides an efficient, accurate, and rapid solution to assist clinicians in identifying and tracking colorectal cancer related conditions.
This in vitro diagnostic (IVD) test is designed for the quantitative detection of carcino-embryonic antigen (CEA test) in human serum, plasma, or whole blood samples. CEA is a well-established tumor marker often elevated in patients with various types of cancer, especially ovarian, lung, breast, pancreatic, and colorectal cancers. With results available in just 15 minutes, the CEA test kit is an ideal point-of-care tool to support quick decision-making and timely interventions.
What Is CEA test and Why Is It Important?
Carcino-embryonic antigen (CEA test) is a glycoprotein involved in cell adhesion and is typically produced in fetal tissues. In healthy adults, CEA test levels are usually low, but they can rise significantly in certain cancer conditions. Measuring CEA in blood is widely used to:
·Monitor treatment response in colorectal cancer patients.
·Detect recurrence or metastasis after surgery or chemotherapy.
·Assess tumor burden in various CEA-producing cancer.
While CEA test is not typically used for primary cancer screening, it plays a vital role in post-treatment surveillance and clinical decision-making. It can also complement imaging and other laboratory findings, providing a more complete diagnostic picture.
Product Highlights
·Fast Results: Obtain quantitative CEA test results in 15 minutes, ideal for emergency rooms, oncology departments, and outpatient clinics.
·Flexible Sample Types: Compatible with serum, plasma, and whole blood samples, increasing clinical utility and accessibility.
·High Sensitivity and Specificity: Provides reliable CEA test, supporting early detection of tumor recurrence or progression.
·User-Friendly Operation: Easy-to-use format suitable for point-of-care testing (POCT), laboratory settings, or field applications.
·Regulatory Compliance: Certified under CE and UKCA, ensuring compliance with international quality and safety standards.
Clinical Applications of the CEA Test Kit
The Carcino-embryonic antigen rapid test is widely applicable across various clinical scenarios:
·Monitoring Colorectal Cancer Treatment: Track how well a patient responds to chemotherapy or surgical interventions by observing changes in CEA test levels.
·Post-Surgical Surveillance: Detect early signs of recurrence, enabling prompt action and improved prognosis.
·Assessing Metastatic Spread: Elevated CEA test results may suggest distant metastasis, guiding further diagnostic imaging or biopsies.
·Differentiating Benign vs. Malignant Conditions: While not diagnostic on its own, the CEA test helps stratify risk and prioritize further testing.
·Supporting Oncologist Workflow: Reduce turnaround times in clinical decision-making with on-the-spot quantitative results.
By choosing the our CEA test kit, healthcare providers gain access to:
·Cost-effective cancer monitoring tools
·Rapid turnaround testing capabilities
·Accurate and reliable tumor marker diagnostics
·Support for real-time clinical decisions
Order Now and Empower Your Clinical Workflow
Stay one step ahead in oncology diagnostics. Equip your practice with the CEA test (Carcino-embryonic antigen) to enable faster, clearer insights into your patients’ cancer status. Whether you're treating colorectal cancer, monitoring for metastasis, or confirming therapeutic progress—the CEA test kit is your dependable partner in cancer care.
Contact us now to request product samples or distributor cooperation details!!
Colorectal cancer
Contact Us
Flora
Whatsapp Business: +86 18030218067
Email: yyfang@wizbiotech.com
